Application Information

Application Number : 2023/011396

Application Date : 24-05-2018

Application Type : EPC Fasikül

Grant Number : 2023-GE-599161

Grant Date : 13-09-2023

Registration Number : 2023 011396

Registration Date : 2023-10-23

Protection Type : Patent

European Patent Publication Number (B1) : EP3630164B1

European Patent Application Number : EP18730908.3

Applicants

Person No	Name	Address
6801224	ELI LILLY AND COMPANY	LILLY CORPORATE CENTER, INDIANAPOLIS, INDIANA 46285 A.B.D.

Inventors

Person No	Name	Address
7562792	Fady Talaat BOTROS	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7562795	Alan George ZIMMERMANN	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7562794	Katherine Rose TUTTLE	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7562793	Mark Chandrakant LAKSHMANAN	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.

Invention Information

Name Of Invention	Kronik böbrek hastalığı tedavisi için dulaglutit.
Summary Of Invention	Bu buluş, makroalbüminüri eşliğinde evre 2-4 kronik böbrek hastalığı (CKD) olan hastalarda CKD tedavisinde kullanım için GLP-1R agonisti dulaglutide ilişkindir.

Attorney Information

Name	SULTAN PINAR ŞEN STOCK FİKRİ MÜLKİYET HİZMETLERİ ANONİM ŞİRKETİ
Address	BÜYÜKDERE CAD. NO:173 LEVENT - ŞİŞLİ- 34394/ İSTANBUL

Priority Information

Date of Priority	Priority Number	Country of Priority
01-06-2017	US 201762513556P	US

Classes of The Invention

Patent Application Procedures

Date	Date of Notification	Operation
30-04-2024		Yıllık Ücret Ödeme Talebi
	22-09-2023	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
13-09-2023		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
23-10-2023	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)
7	2024	30-04-2024	4360.0